Free tool
Rare disease stocks
We cover 184 companies grouped under the Rare disease theme. The median market value in the group is $249.99M. Across the group, the median move over the past trading day is −0.49%. 49% of the 176 with a 200-day average trade above it. Price change over the past year runs from −77.2% to +210.0% across the middle 80 percent of the group, with a median of +5.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
184 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $139.70B | Large cap | −83.18% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| A1RG34.SA | argenx SE | $63.16B | Large cap | +36.97% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $32.28B | Large cap | −10.21% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.35% |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | +71.81% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +4.97% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +48.91% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.88B | Small cap | +5.54% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| PYC.AX | PYC Therapeutics Limited | $1.60B | Small cap | +74.42% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| DBV.PA | DBV Technologies S.A. | $901.25M | Small cap | +60.13% |
| PHAR | Pharming Group N.V. | $845.80M | Small cap | −14.47% |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% |
| AGMB | AgomAb Therapeutics NV | $703.26M | Small cap | −2.53% |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% |
| VALN | Valneva SE | $634.84M | Small cap | −23.49% |
| AYJ.DE | Valneva SE | $619.77M | Small cap | −21.89% |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| 005257.KS | GC Corp. | $547.34M | Small cap | −40.16% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | $487.17M | Small cap | +43.78% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% |
| QTTB | Q32 Bio Inc. | $481.67M | Small cap | +840.70% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +6.92% |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | −1.42% |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $406.58M | Small cap | −9.63% |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $338.48M | Small cap | −24.94% |
| PRQR | ProQR Therapeutics N.V. | $331.63M | Small cap | +6.33% |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% |
| SION | Sionna Therapeutics, Inc. | $282.58M | Small cap | −75.45% |
| ELDN | Eledon Pharmaceuticals, Inc. | $272.22M | Small cap | +29.84% |
| IVVD | Invivyd, Inc. | $265.78M | Small cap | +3.52% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $263.56M | Small cap | +178.15% |
| SLGL | Sol-Gel Technologies Ltd. | $260.05M | Small cap | +261.87% |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% |
| AKBA | Akebia Therapeutics, Inc. | $251.20M | Small cap | −69.88% |
| CRDL | Cardiol Therapeutics Inc. | $250.00M | Small cap | +91.07% |
| CRDL.TO | Cardiol Therapeutics Inc. | $249.99M | Small cap | +90.38% |
| PEPG | PepGen Inc. | $237.21M | Small cap | +159.68% |
| RNA | Prosensa Holding B.V. Ordinary Shares | $236.91M | Small cap | −6.10% |
| SIGA | SIGA Technologies, Inc. | $220.58M | Small cap | −57.93% |
| KROS | Keros Therapeutics, Inc. | $220.48M | Small cap | −28.35% |
| ANTX | AN2 Therapeutics, Inc. | $208.68M | Small cap | +385.09% |
| ARMP | Armata Pharmaceuticals, Inc. | $202.64M | Small cap | +123.36% |
| MSCL.TO | Satellos Bioscience Inc. | $199.95M | Small cap | +81.67% |
| PLX | Protalix BioTherapeutics, Inc. | $199.82M | Small cap | +55.00% |
| MSLE | Satellos Bioscience Inc. | $198.59M | Small cap | +77.27% |
| SPRB | Spruce Biosciences, Inc. | $176.69M | Small cap | +721.93% |
| MDWD | MediWound Ltd. | $163.96M | Small cap | −25.29% |
| EQ | Equillium, Inc. | $149.64M | Small cap | +23.56% |
| AARD | Aardvark Therapeutics, Inc. | $149.04M | Small cap | −24.25% |
| UNCY | Unicycive Therapeutics, Inc. | $148.74M | Small cap | +27.17% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $148.23M | Small cap | −53.59% |
| MIST | Milestone Pharmaceuticals Inc. | $146.91M | Small cap | −33.33% |
| 4599.T | StemRIM | $140.21M | Small cap | +14.75% |
| INO | Inovio Pharmaceuticals, Inc. | $134.42M | Small cap | −47.15% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| DXB.AX | Dimerix Limited | $122.97M | Small cap | −34.83% |
| MDP.TO | Medexus Pharmaceuticals Inc. | $117.29M | Small cap | +66.56% |
| PYPD | PolyPid Ltd. | $103.79M | Small cap | +49.42% |
| PTHS | Pelthos Therapeutics Inc. | $102.53M | Small cap | +12.90% |
| ABNX.PA | ABIONYX Pharma SA | $98.59M | Micro cap | −31.34% |
| ILA.AX | Island Pharmaceuticals Limited | $95.70M | Micro cap | +109.30% |
| FBIO | Fortress Biotech, Inc. | $94.38M | Micro cap | +20.09% |
| PLYX | Polaryx Therapeutics, Inc. | $94.21M | Micro cap | −94.03% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | $92.46M | Micro cap | −24.56% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% |
| RCE.AX | Recce Pharmaceuticals Ltd | $82.40M | Micro cap | −10.71% |
| TELO | Telomir Pharmaceuticals, Inc. | $80.47M | Micro cap | −20.95% |
| TENX | Tenax Therapeutics, Inc. | $79.34M | Micro cap | −64.19% |
| STX.L | Shield Therapeutics plc | $71.97M | Micro cap | −37.42% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| ALTHX.PA | THX Pharma Société Anonyme | $71.22M | Micro cap | +73.96% |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% |
| RNTX | Rein Therapeutics Inc. | $69.01M | Micro cap | −27.27% |
| IMA | ImageneBio, Inc. | $61.64M | Micro cap | −60.19% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| ATYR | aTyr Pharma, Inc. | $54.05M | Micro cap | −89.34% |
| NSRX | Nasus Pharma Ltd. | $48.01M | Micro cap | −49.75% |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% |
| EDSA | Edesa Biotech, Inc. | $47.63M | Micro cap | +105.83% |
| GRCE | Grace Therapeutics, Inc. | $46.28M | Micro cap | −29.97% |
| MREO | Mereo BioPharma Group plc | $44.39M | Micro cap | −84.20% |
| BOT.AX | Botanix Pharmaceuticals Limited | $41.30M | Micro cap | −86.67% |
| NNVC | NanoViricides, Inc. | $32.68M | Micro cap | −9.86% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| IMM.L | ImmuPharma plc | $31.75M | Micro cap | +89.66% |
| 520A.T | J-PHARMACEUTICALS CO LTD | $31.71M | Micro cap | −60.00% |
| ALDVI.PA | Advicenne S.A. | $30.93M | Micro cap | +39.11% |
| 4591.T | Ribomic Inc. | $30.52M | Micro cap | −17.31% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| RVX.TO | Resverlogix Corp. | $24.81M | Micro cap | 0.00% |
| JSPR | Jasper Therapeutics, Inc. | $23.96M | Micro cap | −75.24% |
| TVRD | Tvardi Therapeutics, Inc. | $23.74M | Micro cap | −94.18% |
| 4884.T | Kringle Pharma, Inc. | $22.30M | Micro cap | −11.29% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| KTTA | Pasithea Therapeutics Corp. | $19.05M | Micro cap | −24.30% |
| CALC | CalciMedica, Inc. | $18.06M | Micro cap | −79.74% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| 4881.T | FunPep Company Limited | $15.92M | Micro cap | −55.65% |
| HIND | Vyome Holdings, Inc. | $15.16M | Micro cap | −79.68% |
| ALBPS.PA | Biophytis S.A. | $11.98M | Micro cap | −50.31% |
| AZTR | Azitra, Inc. | $10.48M | Micro cap | −83.21% |
| QNRX | Quoin Pharmaceuticals, Ltd. | $10.40M | Micro cap | −29.81% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | $10.27M | Micro cap | −46.03% |
| PHR.WA | Pharmena S.A. | $9.45M | Micro cap | −8.72% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −35.77% |
| IMC.AX | Immuron Limited | $8.58M | Micro cap | −46.38% |
| SNGX | Soligenix, Inc. | $8.36M | Micro cap | −87.20% |
| XCUR | Exicure, Inc. | $8.25M | Micro cap | −77.93% |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% |
| VBS.AX | Vectus Biosystems Limited | $6.65M | Micro cap | +104.82% |
| PULM | Pulmatrix, Inc. | $5.57M | Micro cap | −68.62% |
| BIOSGN.ST | Biosergen AB (publ) | $5.31M | Micro cap | −94.62% |
| CVKD | Cadrenal Therapeutics, Inc. | $4.80M | Micro cap | −88.87% |
| JAGX | Jaguar Health, Inc. | $4.78M | Micro cap | −98.52% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| GRI | GRI Bio, Inc. | $4.28M | Micro cap | −95.23% |
| XRTX | XORTX Therapeutics Inc. | $4.03M | Micro cap | −43.99% |
| BIT.AX | Biotron Limited | $3.99M | Micro cap | −50.00% |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $3.80M | Micro cap | −78.23% |
| MTNB | Matinas BioPharma Holdings, Inc. | $2.89M | Micro cap | −90.08% |
| ANR.AX | Anatara Lifesciences Ltd | $2.05M | Micro cap | 0.00% |
| APTA.ST | Aptahem AB (publ) | $1.50M | Micro cap | −67.65% |
| APLI.TO | Appili Therapeutics Inc. | $1.44M | Micro cap | −25.00% |
| VBIO | Valion Bio, Inc. | $647.60K | Micro cap | −94.92% |
| ALNEV.PA | Neovacs S.A. | $22.00 | Micro cap | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.